Iterum Therapeutics plc
(NASDAQ: ITRM)

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

0.307 H

+0.273 (+802.94%)
Range 0.028 - 0.047   (67.86%)
Open 0.042
Previous Close 0.034
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 49,297,937
Value 1,361,305
Remark H
Delayed prices. Updated at 01 Apr 2026 04:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis